| Type | Description |
|---|---|
| Definition | prostaglandin E receptor 1 |
| Date | Results | Publications |
|---|---|---|
| 2018-05-19 11:36:00 | No significant differences in EP1 intensity were detected for histological, stage, grading, metastatic and recurrent subtypes in endometrial cancer. | 29134301 |
| 2017-07-01 12:44:00 | COX-2 expression appears to be linked to early hepatocellular carcinoma events (initiation), while EP1 receptor expression may participate in tumor progression and predict survival | 27818595 |
| 2017-03-18 11:04:00 | Copy number variation in PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema | 26959713 |
| 2017-02-18 11:48:00 | suppression of EP1 prevented RAMA-induced FasL suppression in CLT85 cells at both the mRNA and protein levels | 26211005 |
| 2016-04-02 11:49:00 | A transient interaction between COX-2 and EP1 constitutes a feedback loop whereby an increase in COX-2 expression elevates EP1. | 24614038 |
| Type | IDs |
|---|---|
| Synonymous | EP1 |
| Gene |
UniProtKB-ID:
PE2R1_HUMAN
UniprotKB:
P34995
UniParc:
UPI0000140CA1
EMBL:
L22647,
BC039034,
AY275470,
AB065464,
BC051286
Ensembl:
ENSG00000160951
KO:
hsa:5731
|
| Nucleutide sequences |
EMBL-CDS:
AAH51286.1,
AAH39034.1,
AAP32302.1,
AAC37539.1,
BAC05723.1
Ensembl_TRS:
ENST00000292513
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000292513
RefSeq:
NP_000946.2
|
| Others |
UniRef100:
UniRef100_P34995
UniRef90:
UniRef90_P34995
UniRef50:
UniRef50_P34995
UniGene:
Hs.159360
CCDS:
CCDS12309.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员